Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Increased frequency and clinical significance of myeloid-derived suppressor cells in human colorectal carcinoma.

World journal of gastroenterology - 7 Jul 2012

Sun Hong-Li, Zhou Xin, Xue Yi-Feng, Wang Ke, Shen Yun-Feng, Mao Jing-Jue, Guo Hong-Feng, Miao Zong-Ning

Abstract excerpt

AIM: To investigate the frequency and clinical significance of the myeloid-derived suppressor cells (MDSC) in human colorectal carcinoma (CRC). METHODS: Samples of peripheral blood and tumor tissue from 49 CRC patients were analyzed. Mononuclear cells were isolated by Ficoll-Hypaque density gradient centrifugation and were subjected to a flow cytometry-based immunophenotypic analysis. RESULTS: A considerable...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CD11b Antigen
Share to CD18 Antigens

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Separation

Share to Centrifugation, Density Gradient

Share to Lymphatic Metastasis

Share to Myeloid Cells

Share to Sialic Acid Binding Ig-like Lectin 3

Share to Tumor Escape

Source

Open in PubMed Open full text

Identifiers

PMID: 22783056
DOI: 10.3748/wjg.v18.i25.3303
PMCID: PMC3391769

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Increased frequency and clinical significance of myeloid-derived suppressor cells in human colorectal carcinoma.PMID 22783056Read ↗

Myeloid-Derived Suppressor Cells in Colorectal CancerSemantic proximity Read ↗

Tumor-induced myeloid-derived suppressor cells promote tumor progression through oxidative metabolism in human colorectal cancer.Semantic proximity Read ↗

Phenotypes, accumulation, and functions of myeloid-derived suppressor cells and associated treatment strategies in cancer patients.Semantic proximity Read ↗

Myeloid-Derived Suppressor Cells.Semantic proximity Read ↗

Myeloid‐derived suppressor cell heterogeneity in human cancersSemantic proximity Read ↗

Myeloid-Derived Suppressor Cells in Solid TumorsSemantic proximity Read ↗

The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion.Semantic proximity Read ↗

The prognostic value of myeloid derived suppressor cell level in hepatocellular carcinoma: A systematic review and meta-analysis.Semantic proximity Read ↗

Complexity and challenges in defining myeloid-derived suppressor cellsSemantic proximity Read ↗

Complexity and challenges in defining myeloid-derived suppressor cellsSemantic proximity Read ↗

Myeloid derived suppressor cells in physiological and pathological conditions: the good, the bad, and the ugly.Semantic proximity Read ↗

Targeting Myeloid-Derived Suppressor Cell Trafficking as a Novel Immunotherapeutic Approach in Microsatellite Stable Colorectal CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.